Keywords: Shire, Vyvanse, sNDA, ADHA, Mainetenance, Children, USA. FDA

FDA accepts Shire's sNDA for Vyvanse as maintenance treatment

Article | 12 September 2012

Print This

Ireland-headquartered drugmaker Shire (LSE: SHP) that the US Food and Drug Administration has accepted the filing for review of a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in